SpeedWeed

FEBRUARY 21, 2021

February 18, 2021. | Previously, Kaminski and GB Sciences had collaborated on finding mixtures of cannabinoids that would reduce inflammation caused by viruses like HIV. “If The post Cannabis mixtures studied as treatment for COVID inflammation appeared first on SpeedWeed. Published. James Hale.

Treatment 52

Treatment Research and Development Cannabinoids Data 52

TheAnswerPage

JULY 14, 2021

How does THC impact the gastro-intestinal system of a patient with IBD? Also, some cannabinoids increase appetite. A thorough 2021 review article summarized the current research evaluating the relationship between cannabinoid-based medicines and the treatment of IBD. Adv Ther (2021). ” Buckley, M.C.,

Patients 59

Patients Cannabinoids Treatment Conditions 59

Cannabis Law Report

OCTOBER 15, 2021

DNA variations or polymorphisms) in patients with African ancestry. The KGA is a proprietary computational platform built in-house at Goldfinch Bio to identify genetic and environmental causes of kidney diseases in patient subsets and the associated biological targets for therapeutic intervention.

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

TheAnswerPage

OCTOBER 18, 2021

Are there any strategies in which patients with chronic non-cancer pain can find their optimal dosing regimen without consuming high doses of THC? We do not regard cannabinoids as first-line treatments but as adjuvant therapies to be used before opioids if other options fail to control chronic non-cancer pain. 2019;170:118.

Chronic Pain 52

Chronic Pain Therapy Cannabinoids Extraction 52

Cannabis Law Report

DECEMBER 7, 2021

Scientific Reports volume 11 , Article number: 23462 ( 2021 ) Cite this article. Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Metrics details.

Safety 52

Safety Cannabinoids Events Data 52

TheAnswerPage

OCTOBER 21, 2021

How long should the testing period of a cannabinoid-based drug be? According to the European Pain Federation position paper on the appropriate use of cannabis-based medicines, “a testing period of maximum 3 months should be considered both by patients and prescribers [or recommenders], to assess treatment efficacy and safety.

Chronic Pain 59

Chronic Pain Treatment Therapy Safety 59

TheAnswerPage

JULY 5, 2021

There is a high strength of evidence for the efficacy of cannabinoid-based medicines for the treatment of intractable epilepsy, multiple sclerosis and cancer-related nausea. Which of these 3 conditions has the greatest relative number of patients using cannabinoid -based medicines to treat the condition? Schlag, A.K.,

Epilepsy 52

Epilepsy Cannabinoids Medicine Conditions 52

TheAnswerPage

MAY 18, 2021

Cannabinoids have been shown to ameliorate some of the symptoms associated with cancer and the side effects associated with some cancer treatments, however, cannabinoids have not been shown to be an effective anti-cancer agent in humans. A survey of breast cancer patients’ use of cannabis before, during, and after treatment.

Treatment 59

Treatment Cannabinoids Conditions Patients 59

TheAnswerPage

JULY 7, 2021

According to the Minnesota database and other reports, the number of people using cannabinoid-based medicines to treat PTSD is increasing. Does the literature support the use of cannabinoids to treat PTSD? However, most of the studies were small and assessed to be of low quality. Schlag, A.K., O’Sullivan, S.E,

Cannabinoids 52

Cannabinoids Sleep Treatment Patients 52

TheAnswerPage

APRIL 29, 2021

Do some cannabinoids reduce spasticity? The cannabinoids act on the presynaptic CB1 receptors, and the receptor activation reduces massive glutamate release and regulates glutamatergic excitability during spasticity.

Cannabinoids 59

Cannabinoids Extraction Treatment Medicine 59

Veriheal

FEBRUARY 1, 2022

A Look Into Dystonia Patients and Cannabis. Research findings presented at the International Congress of Parkinson’s Disease and Movement Disorder Society Virtual Congress 2021 showed that adults with dystonia who consumed cannabis were experiencing improvements in their pain and symptoms. years, give or take. times per day.

Treatment 98

Treatment Patients Cannabis Oil 98

The Cannigma

OCTOBER 2, 2022

Additionally, nausea is a common side effect of cancer treatments, migraines, pregnancy, and more. Some of the earliest studies examine the effects of THC on cancer patients and reducing chemo-related nausea, although the scientists noted the effectiveness of THC can be dependent on tolerance, dose, and administration. CBDA and nausea.

Terpenes 113

Terpenes Strains THC Oil 113

TheAnswerPage

MAY 14, 2021

According to the results of a survey of breast cancer patients’ use of cannabinoid products, 42% of survey participants had used medical cannabinoid products to relieve symptoms. What symptoms were treated with cannabinoid products? A survey of breast cancer patients’ use of cannabis before, during, and after treatment.

Cannabinoids 52

Cannabinoids Patients Treatment Cannabis 52

Veriheal

DECEMBER 8, 2021

Fortunately, a new study found that cannabidiol (CBD) can be useful in the treatment of traumatic brain injury. Adding to the seriousness of a TBI is the fact that there are currently no universally effective treatments—which is what makes the findings of this new study especially significant. or CBDi treatment alone.”

CBD 98

CBD Treatment Therapy Chronic Pain 98

Cannabis Law Report

AUGUST 13, 2021

Derived from Salvia divinorum, SalA is a unique non-nitrogenous agonist of the kappa-opioid receptor (KOR) with potential use in treatment-resistant depression (TRD), substance use disorder (SUD) and pain. Clinically, there are published reports of the potential benefits of Salvia divinorum in the treatment of TRD. BERLIN, Aug.

Conditions 105

Conditions Research and Development Clinical Trials Treatment 105

TheAnswerPage

NOVEMBER 12, 2021

Nabiximols is indicated as treatment for symptom improvement in adult patients with moderate to severe spasticity due to multiple sclerosis who have not responded adequately to other anti-spasticity medication and who demonstrate clinically significant improvement in spasticity related symptoms during an initial trial of therapy.

Therapy 59

Therapy Patients Treatment Cannabinoids 59

TheAnswerPage

MAY 17, 2021

Epidemiological studies indicate that as many as 15% of inflammatory bowel disease (IBD) patients may use cannabinoids to ameliorate some of their symptoms, including improvement in diarrhea, abdominal pain and appetite. Do the studies show that cannabinoids are effective in Crohn’s disease? Naftali T, Dor M. See Answer.

Cannabinoids 52

Cannabinoids Treatment Medicine THC 52

The Cannigma

DECEMBER 20, 2022

Medical marijuana is legal in Estonia, but the program is limited and only includes cannabinoid-based medications. Nonetheless, a 2021 statement by the Minister of Interior stated that Estonia was not yet ready to legalize any drugs, including cannabis. Medical: legal, no program Recreational: illegal (largely decriminalized).

Law 52

Law Decriminalization Cannabinoids Treatment 52

The Cannigma

JULY 21, 2021

The acclaimed cannabis chemovar (strain) “ Headband ” was named as one of the three most popular for migraine and headache patients, in a new study released in June, 2021. The study , compiled by Dr. Eric Baron from the Cleveland Clinic and Philippe Lucas from cannabis firm Tilray , surveyed 346 migraine patients using cannabis.

Strains 145

Strains Terpenes Chronic Pain Patients 145

TheAnswerPage

MAY 29, 2021

A common adverse effect of chronic recreational marijuana use is cannabinoid hyperemesis syndrome. In fact, cannabinoid hyperemesis syndrome is a near daily diagnosis in many Canadian emergency departments. Anecdotal evidence supports the use of haloperidol to treat cannabinoid hyperemesis syndrome. mg/kg or 0.1

Clinical Trials 52

Clinical Trials Cannabinoids Treatment Recreational 52

MMJ Recs

MAY 30, 2021

The California MMJ program is one of the most well-run and patient-friendly in the US. And how much does it cost to get an MMJ card in California in 2021? How Do You Get A Medical Card In California In 2021? How Much Does It Cost To Get A Medical Card In California In 2021? How do you apply for an MMJ card in California?

Dispensary 52

Dispensary Recreational Tincture Chronic Pain 52

TheAnswerPage

JULY 24, 2022

The “Cannabinoid-based Medications for the Treatment of Chronic Pain” series continues… The guideline development panel of the “Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline” evaluated patients’ values and preferences related to medical cannabis or cannabinoids for chronic pain.

Chronic Pain 52

Chronic Pain Cannabinoids Treatment Patients 52

The Cannigma

MAY 5, 2021

An unknown number of recovered COVID-19 patients are walking through a fog, uncertain when it will end and what can be done to help. Scientists are still not sure, but one study carried out in Italy in 2020 found that out of 143 patients who had recovered from COVID-19, 87.4% How common is long COVID? episodes per month.

Chronic Pain 144

Chronic Pain Research and Development Patients Treatment 144

TheAnswerPage

JANUARY 10, 2022

How does THC impact the gastro-intestinal system of a patient with IBD? Also, some cannabinoids increase appetite. A thorough 2021 review article summarized the current research evaluating the relationship between cannabinoid-based medicines and the treatment of IBD. Adv Ther (2021). ” Buckley, M.C.,

Patients 59

Patients Cannabinoids Treatment Conditions 59

TheAnswerPage

JULY 25, 2022

The “Cannabinoid-based Medications for the Treatment of Chronic Pain” series continues… The guideline development panel of the “Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline” evaluated patients’ values and preferences related to medical cannabis or cannabinoids for chronic pain.

Chronic Pain 52

Chronic Pain Cannabinoids Therapy Patients 52

Cannabis Law Report

FEBRUARY 17, 2022

Peru represented 5% of the total Latin America unit sales in 2021. In the second half of 2021, the Company opened its first Zerenia™ clinic in Lima , in partnership with Clínica Montesur. Since opening the clinic, over 80% of the consults resulted in cannabis prescriptions.

Patients 52

Patients Treatment Access Collective 52

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. About Curaleaf International.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

JUNE 9, 2021

NEW YORK & LEAMINGTON, Ontario–(BUSINESS WIRE)–Jun 8, 2021– Tilray, Inc. Simon, Tilray’s Chief Executive Officer, said, “Medical cannabis innovation and patient care are core to the new Tilray’s business and global growth strategy. About Aphria, Tilray’s Medical Cannabis Brand.

Topical 102

Topical Patients Oil Cannabinoids 102

TheAnswerPage

JULY 21, 2022

An international guideline development panel including patients, clinicians with content expertise, and methodologists addressed the question: “What is the role of medical cannabis or cannabinoids for people living with chronic pain due to cancer or non-cancer causes?” See the Answer.

Chronic Pain 52

Chronic Pain Research and Development Cannabinoids Safety 52

The Cannigma

MARCH 2, 2021

They argued that their findings suggest that doctors “outside of the VHA system who treat veteran patients may need to take the lead in conversations surrounding medical marijuana as a treatment option.”. While medical marijuana is a legal treatment option in 33 states and Washington D.C., Pain management was mentioned by 7.8%

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

The Cannigma

JUNE 23, 2022

While CBG (cannabigerol) has been hailed ‘the mother of all cannabinoids,’ it’s time to reveal the true heir to the throne – cannabigerolic acid, or CBGA. This cannabinoid has only recently been studied, and future studies will certainly divulge its exact importance. What is the difference between CBG and CBGa? What does CBGA do?

Cannabinoids 113

Cannabinoids Research and Development Clinical Trials Extraction 113

Cannabis Law Report

JUNE 17, 2021

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. The May 4, 2021 guidance for revenue was in the range of $2.5 – $2.7 That has been increased as of June 17, 2021, to a range of $3.0

Pharmaceutical 108

Pharmaceutical Clinical Trials Therapy Programs 108

Cannabis Law Report

NOVEMBER 3, 2021

Khiron in the United Kingdom The company is pursuing a consistent approach to improve patient access to medical cannabis and to develop the market for medical cannabis treatments in the UK. This is a great milestone for Khiron and will contribute significantly to the dynamics of developing a market for medical cannabis in the UK.

Therapy 52

Therapy Access Patients Treatment 52

Cannabis Law Report

OCTOBER 29, 2021

NYSE American: IGC) announces its financial results for the three months ended September 30, 2021, which is the second quarter of the Company’s 2022 fiscal year. The Company believes that this may be the first such filing using low doses of a natural phytocannabinoid, THC, on patients suffering from Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

Veriheal

MAY 6, 2022

Millions of post-traumatic stress disorder (PTSD) patients around the world—such as ex-veterans and military servicemen—tend to relive their traumatic flashbacks and experiences during sleep. ” The mind-altering cannabinoid may also increase the weirdness factor of a consumer’s dreams. Does CBD Impact REM Sleep?

Sleep 98

Sleep Cannabinoids THC CBD 98

Cannabis Law Report

SEPTEMBER 15, 2021

More than 100 people in the US have been hospitalized in 2021 after using Delta-8 THC products, federal health regulators warned Tuesday. Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant. The FDA aren’t sending mixed messages.

THC 105

THC Pets Events Hemp 105